{"id":203381,"name":"EXELIXIS INC.","slug":"exelixis-inc","state":"CA","country":"United States of America","description":"","totalSpending":10700000,"filings":31,"yearlySpending":[{"year":2019,"income":990000},{"year":2020,"income":920000},{"year":2021,"income":950000},{"year":2022,"income":1240000},{"year":2023,"income":1810000},{"year":2024,"income":1830000},{"year":2025,"income":2960000}],"issues":["HCR","TAX"],"firms":["EXELIXIS INC."],"lobbyists":["JAMES FENTON","ERIN HERMANCE","JARED MICHAUD"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues relating to pharmaceutical pricing","Issues related to pharmaceutical access and pricing.","The Creating & Restoring Equal Access to Equivalent Samples (\"CREATES\") Act of 2019 and issues related to pharmaceutical access and pricing.","The Creating & Restoring Equal Access to Equivalent Samples (\"CREATES\") Act of 2019 and issues related to pharmaceutical access and pricing.","HR 3-Elijah E. Cummings Lower Drug Costs Now Act; S.2543-Prescription Drug Pricing Reduction Act of 2019; and The Creating & Restoring Equal Access to Equivalent Samples (\"CREATES\") Act of 2019."],"years":[2019,2020,2021,2022,2023,2024,2025]}